APSARD Conference Closing Keynote

What's Next? Adult ADHD Guidelines & the Public Health Implications with the CDC, DEA, FDA, & Policy Advocates

What’s next for adult ADHD care? Hear from the CDC, DEA, FDA, and policy advocates on emerging guidelines and their public health implications. This closing keynote explores where federal priorities align, what’s changing in regulation and access, and how you can help shape the road ahead.

Saturday, January 16th, 4:00 - 5:30pm

Katie Laughery, M.S.

Panelist

Deputy Assistant Administrator

U.S. Drug Enforcement Administration

Lara Robinson, PhD, MPH

Panelist

Lead Health Scientist

Centers for Disease Control & Prevention

Tiffany Farchione, MD, FAPA

Panelist

Director, Division of Psychiatry

U.S. Food & Drug Administration

Chair: Tim Wilens, MD

Professor of Psychiatry, Harvard Medical School

Psychiatrist, Massachusetts General Hospital

AACAP President-Elect

Don't miss the latest insights in ADHD research and closing session - register for the 2027 Annual Conference.

Join us at #APSARD2027

Secure your seat at these sessions - register today to guarantee your place.

View Full Conference Schedule

YouTube

Executive Office

info@apsard.org // Tel: +1 615-649-3083 // apsard.org